Larimar Therapeutics News

Larimar Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 9 02:44

Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Second Quarter 2024 Operating and Financial Results

Aug 7 19:06

Larimar Therapeutics | 8-K: Current report

Jun 10 18:08

Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Flynn James E

Jun 4 06:36

Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hamilton Thomas Edward

Jun 1 05:00

Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Truitt Joseph

Jun 1 05:00

Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SHERMAN JEFFREY W

Jun 1 05:00

Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LEFF JONATHAN S

Jun 1 05:00

Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director THOMAS FRANK E

Jun 1 05:00

Larimar Therapeutics | 8-K: Current report

Jun 1 04:19

Larimar Therapeutics | 8-K: Current report

May 31 04:15

Larimar Therapeutics | EFFECT: Others

May 28 18:06

Larimar Therapeutics | CORRESP: CORRESP

May 23 02:40

Larimar Therapeutics | 8-K: Current report

May 21 04:12

Larimar Therapeutics | UPLOAD: Others

May 17 02:40

Larimar Therapeutics | S-3: Registration statement for specified transactions by certain issuers

May 10 04:56

Larimar Therapeutics | 10-Q: Q1 2024 Earnings Report

May 10 04:22

Larimar Therapeutics | 8-K: Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results

May 9 19:07

Larimar Therapeutics | ARS: Annual Report to Security Holders

Apr 30 04:09

Larimar Therapeutics | DEF 14A: Definitive information statements

Apr 30 04:09